Ironwood Pharmaceuticals (IRWD) Notes Payables (2012 - 2020)

Ironwood Pharmaceuticals (IRWD) has 8 years of Notes Payables data on file, last reported at $400000.0 in Q3 2020.

• For the quarter ending Q3 2020, Notes Payables fell 74.89% year-over-year to $400000.0; the trailing twelve-month figure through Sep 2020 stood at $400000.0 (down 74.89% YoY), and the FY2019 full-year result was $1.5 million, down 96.83% from the prior year.
• Notes Payables fell to $400000.0 in Q3 2020, from $751000.0 in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $48.8 million in Q2 2019 to a low of $1000.0 in Q4 2016.
• A 4-year average of $19.7 million and a median of $12.0 million in 2018 frame the typical range for Notes Payables.
• Across the five-year window, Notes Payables surged 284.35% in 2019 and slumped 98.46% in 2020, its largest moves.
• Tracing IRWD's Notes Payables over 4 years: stood at $1000.0 in 2016, then jumped by 4755300.0% to $47.6 million in 2018, then slumped by 96.83% to $1.5 million in 2019, then slumped by 73.49% to $400000.0 in 2020.
• Business Quant data shows IRWD's Notes Payables at $400000.0 in Q3 2020, $751000.0 in Q2 2020, and $1.1 million in Q1 2020.